F Dx Advisors, Inc. Emergent Bio Solutions Inc. Transaction History

F Dx Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	BUY	$49.34 - $68.76 $1.68 Million - $2.34 Million	33,983 New	33,983 $37,000
Q2 2019 Jul 19, 2019	SELL	$39.92 - $53.86 $200,518 - $270,538	-5,023 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$48.23 - $66.16 $238,931 - $327,756	-4,954 Reduced 49.65%	5,023 $254,000
Q4 2018 Apr 29, 2019	SELL	$55.63 - $73.24 $60,859 - $80,124	-1,094 Reduced 9.88%	9,977 $591,000
Q4 2018 Feb 07, 2019	BUY	$55.63 - $73.24 $71,095 - $93,600	1,278 Added 13.05%	11,071 $656,000
Q3 2018 Nov 13, 2018	SELL	$52.05 - $66.51 $58,816 - $75,156	-1,130 Reduced 10.35%	9,793 $645,000
Q2 2018 Aug 08, 2018	SELL	$48.33 - $55.64 $669,998 - $771,337	-13,863 Reduced 55.93%	10,923 $552,000
Q1 2018 May 02, 2018	BUY	$44.44 - $54.39 $499,727 - $611,615	11,245 Added 83.04%	24,786 $1.31 Million
Q4 2017 Feb 09, 2018	BUY	$37.77 - $47.75 $511,443 - $646,582	13,541	13,541 $629,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.